Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 75.40

+5.5%

Nov 11 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (1710)	12/1/2006 9:22:30 AM
From: Jibacoa	Read Replies (1) of 3722

MGRM Is due to open on an upgap after some news,reversing yesterday's dip.<g> It announced that PFE plans to establish a multi-national Expanded Access Program (EAP) that will make its investigational CCR5 antagonist maraviroc available to HIV/AIDS patients who have limited treatment options due to resistance or intolerance. (MGRM's co-receptor tropism assay, (Trofile), was used for patient selection.) Last month MRGM secured a 10M credit line from MER & had a "buy" recommendation from LAZ & this week also from CE Unterberg Towbin.<g> On a close above $2 it may get to retest its Oct.5 spike at the 2.70 level.<g> bigcharts.marketwatch.com MRGM has a small LTD, trades around 5.2xBV & has a short position close to 16x its daily average volume.The list of institutional & mutual fund holders is pretty good for a stock of this price level.<g> finance.yahoo.com Its LTC is "interesting" <g> bigcharts.marketwatch.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next